GRRR:NASDAQGorilla Technology Group Inc. Analysis
Data as of 2026-04-07 - not real-time
$10.84
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Gorilla Technology Group posted a record $101.4 million in revenue for FY2025, a 35.7% year‑over‑year increase, and EPS jumped 91.7% YoY, signaling strong top‑line momentum and improving profitability. However, the company still reports a negative trailing EPS of -$0.51 and operating cash flow remains in the red, while debt‑to‑equity sits at a lofty 7.47, highlighting cash‑flow and leverage concerns. Technically, the stock trades below its 20‑day and 50‑day moving averages, indicating a bearish trend, yet the MACD histogram is positive and RSI hovers near neutral, suggesting short‑term upside potential toward the resistance level of $12.23. With a forward PE of 7.74 versus an industry average of 33.7, the valuation appears significantly undervalued, and analyst price targets imply a potential upside of over 200% from the current $10.84 price.
The high 30‑day volatility (≈75%) and a beta near 1.9 point to pronounced price swings, while stable volume and a modest market cap keep liquidity adequate but not robust. Given the mix of strong revenue growth, an expansive $7 billion pipeline, and substantial valuation discounts, the stock presents a compelling growth‑value case, albeit tempered by cash‑flow deficits, high leverage, and sector‑specific regulatory exposure.
The high 30‑day volatility (≈75%) and a beta near 1.9 point to pronounced price swings, while stable volume and a modest market cap keep liquidity adequate but not robust. Given the mix of strong revenue growth, an expansive $7 billion pipeline, and substantial valuation discounts, the stock presents a compelling growth‑value case, albeit tempered by cash‑flow deficits, high leverage, and sector‑specific regulatory exposure.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Positive MACD histogram and neutral RSI suggest near‑term bullish momentum
- Record revenue growth and EPS improvement boost confidence
- Technical support near $9.04 provides downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Forward PE of 7.74 vs industry 33.7 indicates strong valuation upside
- $7 billion pipeline and continued revenue acceleration
- Analyst price targets imply >200% upside potential
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Negative operating cash flow and high debt‑to‑equity raise sustainability concerns
- High volatility and beta increase exposure to market swings
- Long‑term growth prospects remain attractive if cash‑flow turns positive
Key Metrics & Analysis
Financial Health
Revenue Growth4.80%
Profit Margin-11.13%
P/E Ratio7.7
ROE-8.38%
ROA2.16%
Debt/Equity7.47
P/B Ratio1.4
Op. Cash Flow$-28924084
Free Cash Flow$-17455020
Industry P/E33.7
Technical Analysis
TrendBearish
RSI48.1
Support$9.04
Resistance$12.23
MA 20$10.88
MA 50$11.81
MA 200$15.38
MACDBullish
VolumeStable
Fear & Greed Index76.5
Valuation
Target Price$36.67
Upside/Downside238.25%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.90
Volatility75.32%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.